Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
Conditions: Advanced Pancreatic Cancer Interventions: Drug: statin addition to chemotherapy Sponsors: Changhai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Conditions: Hyperlipidemias Interventions: Drug: SGB-3403; Other: Atorvastatin; Other: Placebo Sponsors: Suzhou Sanegene Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Topical Statin Eye Drop in the Management of the Dry Eye
Conditions: Dry Eye Disease Interventions: Drug: Statin eye drop; Drug: Placebo Sponsors: Shahid Beheshti University of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin
Conditions: Healthy Volunteers Interventions: Drug: Avacopan; Drug: Simvastatin Sponsors: Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
ATORvastatin in Pulmonary TUBerculosis
Conditions: Pulmonary Tuberculosis; Tuberculosis; Koch ' s Disease Interventions: Drug: Atorvastatin 20mg; Drug: Atorvastatin 40mg; Drug: Atorvastatin 60mg Sponsors: Obafemi Awolowo University Teaching Hospital; Open Philanthropy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Conditions: Healthy Volunteers Interventions: Drug: Atorvastatin; Drug: ALG-055009; Drug: Rosuvastatin Sponsors: Aligos Therapeutics Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Conditions: Healthy; Obese; Overweight Interventions: Drug: Orforglipron; Drug: Simvastatin; Drug: Digoxin; Drug: Rosuvastatin; Drug: Acetaminophen; Drug: Midazolam; Drug: Sodium Bicarbonate Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Bioequivalence Study of Simvastatin 40 mg Film-coated Tablets in Healthy Thai Volunteers
Conditions: Healthy Volunteer Interventions: Drug: Simvastatin 40 mg film-coated tablet; Drug: Zocor 40 mg film-coated tablet Sponsors: International Bio service Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma
Conditions: Clinical Stage IIA Cutaneous Melanoma AJCC v8 Interventions: Drug: Atorvastatin; Drug: Placebo Administration; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Other: Electronic Health Record Review Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Kuni Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Conditions: Coronary Artery Disease; Nephropathy; Toxic, Drugs Interventions: Drug: Atorvastatin 80mg; Drug: N-acetyl cysteine; Other: Normal Saline Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
Conditions: Acute Metabolic Effects of Evolocumab and Atorvastatin Interventions: Drug: Evolocumab Sponsors: Region Stockholm; Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: Statins; Drug: Evolocumab Sponsors: Xuanwu Hospital, Beijing Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Interventions: Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); Sponsors: Peking University People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Conditions: Acute Coronary Syndrome; Non ST Segment Elevation Acute Coronary Syndrome Interventions: Drug: Tafolecimab; Drug: Cholesterol Absorption Inhibitor; Drug: Statin Sponsors: China National Center for Cardiovascular Diseases; Innovent Biologics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: Atorvastatin; Drug: Rosuvastatin; Other: No drugs Sponsors: Pomeranian Medical University Szczecin Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
